SUNRISE, Fla., March 1, 2012 (GLOBE NEWSWIRE) -- Dear Shareholders,
It is with great enthusiasm that I am pleased to inform you about Bioheart’s progress during 2011 and announce several new initiatives for 2012. We have boosted our senior management team, entered into several valuable partnerships and agreements, identified new markets and alternative sources of revenue and seen tangible results regarding continued clinical trials.